The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 12, 2024
Filed:
Dec. 14, 2023
Applicant:
Alpheus Medical, Inc., Chanhassen, MN (US);
Inventors:
Vijay Agarwal, New York, NY (US);
Braden Eliason, Minneapolis, MN (US);
Jeremy Ling, Mendota Heights, MN (US);
Assignee:
Alpheus Medical, Inc., Chanhassen, MN (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61N 7/00 (2006.01); A61B 17/00 (2006.01); A61B 17/32 (2006.01); A61B 18/00 (2006.01); A61F 7/00 (2006.01); A61F 7/02 (2006.01); A61K 9/00 (2006.01); A61K 31/197 (2006.01); A61K 41/00 (2020.01); A61M 21/00 (2006.01); A61M 21/02 (2006.01); A61P 35/00 (2006.01); B06B 1/02 (2006.01); B06B 1/06 (2006.01);
U.S. Cl.
CPC ...
A61N 7/00 (2013.01); A61F 7/0085 (2013.01); A61K 9/0053 (2013.01); A61K 31/197 (2013.01); A61K 41/0033 (2013.01); A61K 41/0061 (2013.01); A61M 21/02 (2013.01); A61P 35/00 (2018.01); B06B 1/0207 (2013.01); B06B 1/0622 (2013.01); A61B 2017/00084 (2013.01); A61B 2017/320069 (2017.08); A61B 2018/00023 (2013.01); A61B 2018/00446 (2013.01); A61F 2007/0056 (2013.01); A61F 2007/0096 (2013.01); A61F 2007/0288 (2013.01); A61M 2021/0027 (2013.01); A61M 2021/005 (2013.01); A61N 2007/003 (2013.01); A61N 2007/006 (2013.01); A61N 2007/0073 (2013.01); A61N 2007/0078 (2013.01); A61N 2007/0082 (2013.01); A61N 2007/0095 (2013.01); B06B 2201/76 (2013.01);
Abstract
Methods of treating tumors by administering compounds to a patient are provided. Compounds such as drugs, may be administered to the patient orally, by injection, intravenously, or topically, which then accumulate as compounds such as a protoporphyrin compound in tumor cells. After such accumulation, such compounds are then activated in various aspects to treat tumors cells, thereby treating cancer. Cancers such as glioblastoma may be treated.